World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
52
Citations
10476
World Ranking
4192
National Ranking
1626

Ann Duerr publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Ann Duerr sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 162 publications — 32nd percentile

32% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Ann Duerr D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Ann Duerr sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 52 D-Index — 25th percentile

25% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Ann Duerr is affiliated with the Fred Hutchinson Cancer Research Center in the United States. Their research primarily focuses on HIV/AIDS, covering various aspects of the disease including interventions, treatment, and related health complications. Their work spans several fields of study such as Medicine and Immunology and Microbiology, with significant contributions to subfields including Infectious Diseases, Epidemiology, and Virology.

Ann Duerr's main topics of research include:

  • HIV/AIDS Research and Interventions
  • HIV Research and Treatment
  • HIV, Drug Use, Sexual Risk
  • Adolescent Sexual and Reproductive Health
  • Sex work and related issues
  • HIV-related health complications and treatments
  • LGBTQ Health, Identity, and Policy

Their recent publications demonstrate an emphasis on understanding HIV persistence and treatment efficacy. Notable papers include:

  • "Single-cell multiomics reveals persistence of HIV-1 in expanded cytotoxic T cell clones," 2022, published in Immunity
  • "Long-term effects of early antiretroviral initiation on HIV reservoir markers: a longitudinal analysis of the MERLIN clinical study," 2021, published in The Lancet Microbe
  • "Single-cell epigenetic, transcriptional, and protein profiling of latent and active HIV-1 reservoir revealed that IKZF3 promotes HIV-1 persistence," 2023, published in Immunity
  • "Evidence of sociodemographic heterogeneity across the HIV treatment cascade and progress towards 90-90-90 in sub-Saharan Africa - a systematic review and meta-analysis," 2020, published in Journal of the International AIDS Society
  • "Persistence of oral pre-exposure prophylaxis (PrEP) among adolescent girls and young women initiating PrEP for HIV prevention in Kenya," 2020, published in AIDS Care

Ann Duerr frequently collaborates with a range of co-authors, including:

  • Javier R. Lama (25 publications)
  • Rachel Bender Ignacio (12 publications)
  • Sayan Dasgupta (12 publications)
  • Delia Pinto-Santini (10 publications)
  • Hugo Sánchez (9 publications)

Their scholarly output is often published in the following venues:

  • UNC Libraries (7 publications)
  • AIDS Care (6 publications)
  • PLoS ONE (5 publications)
  • arXiv (Cornell University) (4 publications)
  • Journal of the International AIDS Society (3 publications)

Best Publications

  • Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial.

    Susan P Buchbinder;Devan V Mehrotra;Ann Duerr;Daniel W Fitzgerald

  • Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women.

    Linda Ahdieh;Robert S. Klein;Robert Burk;Susan Cu-Uvin

  • Bacterial vaginosis and HIV seroprevalence among female commercial sex workers in Chiang Mai, Thailand

    Craig R. Cohen;Ann Duerr;Niwat Pruithithada;Sungwal Rugpao

  • Extended Follow-up Confirms Early Vaccine-Enhanced Risk of HIV Acquisition and Demonstrates Waning Effect Over Time Among Participants in a Randomized Trial of Recombinant Adenovirus HIV Vaccine (Step Study)

    Ann Duerr;Yunda Huang;Susan Buchbinder;Robert W. Coombs

  • Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial

    Morgane Rolland;Sodsai Tovanabutra;Allan C deCamp;Nicole Frahm

  • Human Papillomavirus Type 16 and Immune Status in Human Immunodeficiency Virus-Seropositive Women

    Howard D. Strickler;Joel M. Palefsky;Keerti V. Shah;Kathryn Anastos

  • Male viral load and heterosexual transmission of HIV-1 subtype E in northern Thailand

    Sodsai Tovanabutra;Valerie Robison;Jeerang Wongtrakul;Supaluk Sennum

  • Overview of STEP and Phambili trial results: two phase IIb test-of-concept studies investigating the efficacy of MRK adenovirus type 5 gag/pol/nef subtype B HIV vaccine.

    Glenda Gray;Susan Buchbinder;Ann Duerr

  • Single-cell multiomics reveals persistence of HIV-1 in expanded cytotoxic T cell clones.

    Unknown

  • Merck Ad5/HIV induces broad innate immune activation that predicts CD8 + T-cell responses but is attenuated by preexisting Ad5 immunity

    Daniel E. Zak;Erica Andersen-Nissen;Eric R. Peterson;Alicia Sato

  • Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine

    Nicole Frahm;Allan C. DeCamp;David P. Friedrich;Donald K. Carter

  • Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.

    Paula Schuman;Suzanne E. Ohmit;Robert S. Klein;Ann Duerr

  • Peptide selection for human immunodeficiency virus type 1 CTL-based vaccine evaluation.

    Fusheng Li;Uma Malhotra;Peter B. Gilbert;Natalie R. Hawkins

  • Longitudinal analysis of bacterial vaginosis: findings from the HIV epidemiology research study.

    Denise J. Jamieson;Ann Duerr;Robert S. Klein;Pangaja Paramsothy

  • Changes in Sexual Behavior and STI Diagnoses Among MSM Initiating PrEP in a Clinic Setting.

    Michalina A Montaño;Julia C Dombrowski;Julia C Dombrowski;Sayan Dasgupta;Matthew R Golden;Matthew R Golden

  • Incident and persistent vulvovaginal candidiasis among human immunodeficiency virus–infected women: Risk factors and severity

    Ann Duerr;Charles M. Heilig;Susan F. Meikle;Susan Cu-Uvin

  • Violence Among Women with or at Risk for HIV Infection

    David Vlahov;Dina Wientge;Jan Moore;Colin Flynn

  • Characterization of genital human papillomavirus infection in women who have or who are at risk of having HIV infection.

    Denise J. Jamieson;Ann Duerr;Robert Burk;Robert S. Klein

  • HIV vaccines: new frontiers in vaccine development.

    Ann Duerr;Judith N. Wasserheit;Judith N. Wasserheit;Lawrence Corey

  • Male Viral Load and Heterosexual Transmission of HIV‐1 Subtype E in Northern Thailand

    Unknown

  • The Use of Nonhuman Primate Models in HIV Vaccine Development

    Cecilia Morgan;Marta Marthas;Christopher Miller;Ann Duerr

  • Mucosal Candidal Colonization and Candidiasis in Women with or at Risk for Human Immunodeficiency Virus Infection

    Paula Schuman;Jack D. Sobel;Suzanne E. Ohmit;Kenneth H. Mayer

  • The impact of HIV infection and immunodeficiency on human papillomavirus type 6 or 11 infection and on genital warts.

    Michael J. Silverberg;Linda Ahdieh;Alvaro Muñoz;Kathryn Anastos

Frequent Co-Authors

Denise J. Jamieson
Denise J. Jamieson Emory University
M. Juliana McElrath
M. Juliana McElrath University of Washington
Lawrence Corey
Lawrence Corey Fred Hutchinson Cancer Research Center
Peter B. Gilbert
Peter B. Gilbert Fred Hutchinson Cancer Research Center
Susan Buchbinder
Susan Buchbinder University of California, San Francisco
Susan Cu-Uvin
Susan Cu-Uvin Brown University
Nicole Frahm
Nicole Frahm Fred Hutchinson Cancer Research Center
Kenneth H. Mayer
Kenneth H. Mayer Harvard Medical School
Robert S. Klein
Robert S. Klein Washington University in St. Louis
Gavin J. Churchyard
Gavin J. Churchyard Aurum Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in microbiology, exploring related online degrees can open doors to diverse healthcare and science career paths. For instance, those drawn to healthcare administration might consider degrees in health information management, which focus on managing patient data and healthcare systems efficiently. To find quality programs, reviewing the best online cahiim accredited health information management degree programs is a smart place to start.

Another growing area is medical billing and coding, essential for the smooth operation of healthcare offices. Students can quickly gain credentials through fast track medical billing and coding certificate online programs, which offer a rapid path into the workforce.

Certification plays a critical role here as well. Achieving a recognized credential, such as the one detailed in cpc certification salary overviews, can significantly boost earning potential and career growth.

Health information managers, for example, enjoy competitive salaries and vital roles in healthcare settings. Exploring the health information management salary details can provide insight into the benefits of this career pathway.

Best Scientists Citing Ann Duerr

Trending Scientists

Recently Published Articles